NASDAQ:AMIX Autonomix Medical (AMIX) Stock Price, News & Analysis $1.79 0.00 (-0.22%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$1.80 +0.02 (+1.06%) As of 06:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Autonomix Medical Stock (NASDAQ:AMIX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Autonomix Medical alerts:Sign Up Key Stats Today's Range$1.76▼$1.8350-Day Range$1.61▼$2.5352-Week Range$1.52▼$56.00Volume30,920 shsAverage Volume314,061 shsMarket Capitalization$4.40 millionP/E RatioN/ADividend YieldN/APrice Target$16.50Consensus RatingBuy Company OverviewAutonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Read More… Autonomix Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks46th Percentile Overall ScoreAMIX MarketRank™: Autonomix Medical scored higher than 46% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingAutonomix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAutonomix Medical has only been the subject of 1 research reports in the past 90 days.Read more about Autonomix Medical's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Autonomix Medical are expected to grow in the coming year, from ($10.00) to ($5.22) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Autonomix Medical is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Autonomix Medical is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAutonomix Medical has a P/B Ratio of 0.22. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.34% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently increased by 121.52%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAutonomix Medical does not currently pay a dividend.Dividend GrowthAutonomix Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.34% of the float of Autonomix Medical has been sold short.Short Interest Ratio / Days to CoverAutonomix Medical has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Autonomix Medical has recently increased by 121.52%, indicating that investor sentiment is decreasing significantly. News and Social Media1.5 / 5News Sentiment-0.38 News SentimentAutonomix Medical has a news sentiment score of -0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Autonomix Medical this week, compared to 1 article on an average week.Search InterestOnly 2 people have searched for AMIX on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Autonomix Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Autonomix Medical insiders have not sold or bought any company stock.Percentage Held by Insiders32.40% of the stock of Autonomix Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 10.78% of the stock of Autonomix Medical is held by institutions.Read more about Autonomix Medical's insider trading history. Receive AMIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Autonomix Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address AMIX Stock News HeadlinesAutonomix Medical, Inc. Announces Follow-On Phase of Clinical Trial to Expand Treatment Options for Cancer Pain ManagementMay 15, 2025 | nasdaq.comAutonomix Medical, Inc. Granted Key U.S. Patent for Innovative Catheter-Based Platform TechnologyMay 15, 2025 | globenewswire.comA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. May 22, 2025 | Porter & Company (Ad)Autonomix CEO Brad Hauser to Present at Virtual Investor's Closing Bell EventMay 14, 2025 | globenewswire.comBrad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable MarketMay 13, 2025 | finance.yahoo.comBrad Hauser, CEO of Autonomix Medical, Inc. Outlines Follow-On Expansion Study Expected to Begin in Q2 2025, Potentially Doubling Addressable MarketMay 13, 2025 | globenewswire.comAutonomix Highlights Compelling Patient Testimonial Showing Rapid Pain Relief from First-in-Human Proof-of-Concept Trial in Pancreatic Cancer PainMay 5, 2025 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Highlighting Key Learnings from First-In-Human Trial and Extension into Visceral Cancer PainMay 1, 2025 | globenewswire.comSee More Headlines AMIX Stock Analysis - Frequently Asked Questions How have AMIX shares performed this year? Autonomix Medical's stock was trading at $3.76 at the beginning of 2025. Since then, AMIX stock has decreased by 52.5% and is now trading at $1.7860. View the best growth stocks for 2025 here. How were Autonomix Medical's earnings last quarter? Autonomix Medical, Inc. (NASDAQ:AMIX) released its earnings results on Thursday, February, 13th. The company reported ($1.46) earnings per share (EPS) for the quarter. When did Autonomix Medical's stock split? Shares of Autonomix Medical reverse split on Friday, October 25th 2024. A 1-20 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. When did Autonomix Medical IPO? Autonomix Medical (AMIX) raised $11 million in an initial public offering (IPO) on the week of January 29th 2024. The company issued 2,234,222 shares at $5.00 per share. How do I buy shares of Autonomix Medical? Shares of AMIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Autonomix Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Autonomix Medical investors own include Advanced Micro Devices (AMD), Luminar Technologies (LAZR), New Found Gold (NFGC), Tesla (TSLA), Global X Future Analytics Tech ETF (AIQ), Aldeyra Therapeutics (ALDX) and Allegro MicroSystems (ALGM). Company Calendar Last Earnings2/13/2025Today5/21/2025Fiscal Year End3/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:AMIX Previous SymbolNASDAQ:AMIX CIK1617867 Webautonomix.com Phone713-588-6150FaxN/AEmployees1Year FoundedN/APrice Target and Rating Average Stock Price Target$16.50 High Stock Price Target$28.00 Low Stock Price Target$5.00 Potential Upside/Downside+823.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($12.93) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-15,430,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-212.48% Return on Assets-161.13% Debt Debt-to-Equity RatioN/A Current Ratio5.31 Quick Ratio5.31 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$8.12 per share Price / Book0.22Miscellaneous Outstanding Shares2,463,000Free Float1,665,000Market Cap$4.40 million OptionableN/A Beta-3.60 20 Stocks to Sell NowToday, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.Get This Free Report This page (NASDAQ:AMIX) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.